Staff editor
Probiota Global 2022, 28-30 March, is the ideal place to gain the latest knowledge in the field of prebiotics, probiotics and the microbiome.
Axial Therapeutics has published the results of a Clinical Trial investigating a novel molecule for managing symptoms associated with autism.
Probiota 2022: connecting the business and science of the microbiome is back in Copenhagen from the 28th to the 30th March.
DreamTec Research Limited is a biotechnology company working on an oral Covid-19 vaccine that can break through global distribution bottlenecks.
Kaleido Biosciences is exploring the potential of the microbiome to treat disease and improve human health.
Philippe Lagella of the Instituit National de la Rcherche Agronomique - France, talks about the increasing interest in Faecalibacterium prausnitzii and its possible use.
Bacthera in collaboration with Seres Therapeutics announced to manufacture SER-109, an investigational oral microbiome therapeutic to treat recurrent Clostridioides difficile infection (CDI).
The Microbiome Connect: Gut Therapeutics Summit returns face to face on the 7-8 December. Join the list today whilst tickets are still available and don't forget to use MP10 to…
Dr. Raanan Shamir discusses the role that the intestinal microbiota plays in the development of celiac disease.
20 years ago the world leading groups of experts FAO/WTO defined probiotics microorganisms in food and food supplements
